Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon bought 30 shares of the company’s stock in a transaction on Wednesday, January 22nd. The shares were bought at an average cost of GBX 1,362 ($16.77) per share, for a total transaction of £408.60 ($503.02).
Johnson Matthey Stock Performance
LON JMAT traded up GBX 10 ($0.12) on Thursday, reaching GBX 1,367 ($16.83). 387,490 shares of the company’s stock traded hands, compared to its average volume of 583,226. The stock has a 50 day moving average price of GBX 1,384.15 and a 200-day moving average price of GBX 1,512.54. The firm has a market cap of £2.38 billion, a price-to-earnings ratio of 2,356.90, a P/E/G ratio of 49,242.50 and a beta of 0.95. Johnson Matthey PLC has a fifty-two week low of GBX 1,295.54 ($15.95) and a fifty-two week high of GBX 1,917.07 ($23.60). The company has a debt-to-equity ratio of 63.15, a quick ratio of 0.76 and a current ratio of 1.45.
Johnson Matthey (LON:JMAT – Get Free Report) last announced its quarterly earnings results on Wednesday, November 27th. The company reported GBX 57.40 ($0.71) earnings per share for the quarter. Johnson Matthey had a return on equity of 4.39% and a net margin of 0.84%. Equities research analysts predict that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.
Johnson Matthey Cuts Dividend
Analysts Set New Price Targets
Several brokerages recently commented on JMAT. Berenberg Bank decreased their price objective on shares of Johnson Matthey from GBX 1,650 ($20.31) to GBX 1,500 ($18.47) and set a “hold” rating for the company in a research report on Thursday, November 28th. Jefferies Financial Group restated a “buy” rating and set a GBX 1,800 ($22.16) price target on shares of Johnson Matthey in a research note on Tuesday, December 17th.
Get Our Latest Report on Johnson Matthey
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Further Reading
- Five stocks we like better than Johnson Matthey
- How to Invest in the FAANG Stocks
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Technology Stocks Explained: Here’s What to Know About Tech
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What Does Downgrade Mean in Investing?
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.